P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA

• Kristin Koenig,
• Juan Miguel Bergua Burgues,
• Pau Montesinos,
• Alison Walker,
• Dale Bixby,
• Patrick Burke,
• Naval Daver,
• Marina Konopleva,
• Stephen Anthony,
• Fenlai Tan,
• Yi Chen,
• Yu Chen,
• Yue Shen,
• Emily Curran

Affiliations

Kristin Koenig

1 The Ohio State University College of Medicine, Division of Hematology

Juan Miguel Bergua Burgues

2 Hospital San Pedro de Alcantara, Hematology Department

Pau Montesinos

3 University Hospital La Fe, Department of Hematology

Alison Walker

4 H. Lee Moffitt Cancer Center and Research Institute, Division of Malignant Hematology

Dale Bixby

5 Hematology (Internal Medicine), University of Michigan

Patrick Burke

5 Hematology (Internal Medicine), University of Michigan

Naval Daver

6 Department of Leukemia, The University of Texas MD Anderson Cancer Center

Marina Konopleva

6 Department of Leukemia, The University of Texas MD Anderson Cancer Center

Stephen Anthony

7 Newave Pharmaceutical Inc.

Fenlai Tan

7 Newave Pharmaceutical Inc.

Yi Chen

7 Newave Pharmaceutical Inc.

Yu Chen

7 Newave Pharmaceutical Inc.

Yue Shen

8 Guangzhou Lupeng Pharmaceutical Co., Ltd.

Emily Curran

9 University of Cincinnati, Division of Hematology & Oncology